Reductions in HbA@c were significantly greater for empagliflozin @ mg/linagliptin @ mg compared with linagliptin @ mg ( P < @ ) but not compared with empagliflozin @ mg and were significantly greater for empagliflozin @ mg/linagliptin @ mg compared with the individual components ( P < @ for both ) .